N-desalkylflurazepam
- CAS No.
- 2886-65-9
- Chemical Name:
- N-desalkylflurazepam
- Synonyms
- DESALKYLFLURAZEPAM;NORFLUDIAZEPAM;N-desallkylflurazepam;FlurazepaM Related CoMpound F;cm7116;ro5-3367;sch17514;MMK1 TFA;RO 5-3367;nor-Flurazepam
- CBNumber:
- CB4316060
- Molecular Formula:
- C15H10ClFN2O
- Molecular Weight:
- 288.7
- MDL Number:
- MFCD00083443
- MOL File:
- 2886-65-9.mol
Melting point | 204-206°C |
---|---|
Boiling point | 454.0±45.0 °C(Predicted) |
Density | 1.39±0.1 g/cm3(Predicted) |
Flash point | 9℃ |
storage temp. | Sealed in dry,Room Temperature |
solubility | Chloroform (Slightly), Methanol (Slightly) |
form | A neat solid |
pka | 11.55±0.70(Predicted) |
color | White to off-white |
InChI | InChI=1S/C15H10ClFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20) |
InChIKey | UVCOILFBWYKHHB-UHFFFAOYSA-N |
SMILES | N1C2=CC=C(Cl)C=C2C(C2=CC=CC=C2F)=NCC1=O |
CAS DataBase Reference | 2886-65-9(CAS DataBase Reference) |
EWG's Food Scores | 1 |
FDA UNII | X9U41NXR6M |
NIST Chemistry Reference | Norfludiazepam(2886-65-9) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H336 | |||||||||
Precautionary statements | P261-P271-P304+P340+P312-P403+P233-P405-P501 | |||||||||
Hazard Codes | F,T | |||||||||
Risk Statements | 11-23/24/25-39/23/24/25 | |||||||||
Safety Statements | 22-24/25-45-36/37-16-7 | |||||||||
RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution | |||||||||
WGK Germany | 2 | |||||||||
RTECS | DF2370100 | |||||||||
HS Code | 2933997500 | |||||||||
NFPA 704 |
|
N-desalkylflurazepam Chemical Properties,Uses,Production
Description
Desalkylflurazepam (Item No. 18484) is an analytical reference material that is structurally categorized as a benzodiazepine. It is an active metabolite of several benzodiazepines, including flurazepam , flutoprazepam, fludiazepam, midazolam, and quazepam. Desalkylflurazepam inhibits L-type voltage-gated calcium channels (Cav; IC50s = 55 and 37 μM for Cav1.2 and 1.3, respectively) by positively modulating GABAA receptors. It can be detected in urine, serum, and meconium by LC-MS/MS. This product is intended for research and forensic applications.
Chemical Properties
Light Yellow Solid
Uses
The major human metabolite of flurazepam. This is a controlled drug precursor therefore a liscence may be required for purchase
Definition
ChEBI: Desalkylflurazepam is a benzodiazepine.
General Description
N-Desalkylflurazepam (also known as norflurazepam, 2886-65-9) is a benzodiazepine analog and an active metabolite of several other benzodiazepine drugs including flurazepam, flutoprazepam, fludiazepam, midazolam, flutazolam, quazepam, and ethyl loflazepate. It is long-acting, prone to accumulation, and binds unselectively to the various benzodiazepine receptor subtypes. It has been sold as a designer drug from 2016 onward.
Mode of action
N-Desalkylflurazepam is a benzodiazepine analog and an active metabolite of several other benzodiazepine drugs including flurazepam, flutoprazepam, fludiazepam, midazolam, flutazolam, quazepam, and ethyl loflazepate. It is long-acting, prone to accumulation, and binds unselectively to the various benzodiazepine receptor subtypes. It has been sold as a designer drug from 2016 onward.